BioSpace News Archive

Holzer & Holzer, LLC is investigating whether certain statements issued by Trevena, Inc. (“Trevena” or the “Company”) (NASDAQ: TRVN) complied with federal securities laws.

Hurricane Michael threatens to disrupt life-sustaining dialysis treatment for patients in Florida’s Panhandle and surrounding states. In response, the American Kidney Fund (AKF) today activated its Disaster Relief Program to provide emergency financial assistance to patients affected by the storm.

On October 17, 2018, the Cannabis Act will come into force, marking a significant milestone in the Government of Canada’s commitment to legalizing and strictly regulating cannabis to keep it out of the hands of children and to keep profits away from criminals and organized crime

EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, today announced the publication of results from a global Company-sponsored multiple sclerosis (MS) carer survey, as well as the premiere of the #MSInsideOut documentary, Seeing MS from the Inside Out,

Many Americans experience a disconnect between how they define health and how they talk about their health with doctors.

Bardy Diagnostics, Inc. announced today it was awarded an Innovative Technology contract with Vizient, Inc. for the Carnation Ambulatory Monitor

Facilities safeguarded, inventory stockpiled, and company ready for emergency orders

NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the Company will release its third quarter 2018 earnings results on Tuesday, October 30, 2018 after the close of the market.

Kala Pharmaceuticals, Inc. (“Kala”) (NASDAQ:KALA), a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary mucus-penetrating particle (MPP) technology, announced today that the underwriters of its previously announced public offering have exercised in full their option to purchase an additional 1,125,000 shares of common stock

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release third quarter 2018 financial results after market close on Tuesday, November 6, 2018